Form EFFECT Autolus Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 22, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Michelle Daubar joins Engine Ventures as Partner, Head of Investor Relations & Capital Formation
- SLB Awarded Major Contract by OQEP for Integrated Facility Expansion in Oman
- Enginzyme Raises SEK 75 Million to Advance Its Commercial Biomanufacturing Strategy
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
